This work establishes a diet-dependent effect of GPX4 suppression in primary TNBC tumor growth and identifies a promising new anticancer target for breaking obesity-TNBC links. This evidence concerns the gene GPX4 and obesity due to melanocortin 4 receptor deficiency.